Systemic Lupus Erythematosus  >>  NN9828  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
NN9828 / Almirall
NCT01689025: An Investigation of Safety and Tolerability of NNC0114-0006 in Subjects With Systemic Lupus Erythematosus (SLE)

Terminated
1
10
US, Europe, RoW
NNC0114-0006, placebo
Novo Nordisk A/S
Inflammation, Systemic Lupus Erythematosus
02/14
02/14

Download Options